Wechselwirkungen · Kymriah
Kymriah 1.2 × 106 – 6 × 108 cells dispersion for infusion · Abschnitt 4.5 · PDF-Seite 10
HOS-134869 · Präparat HOS-097630
No pharmacokinetic or pharmacodynamic drug interaction studies with tisagenlecleucel have been performed in either the paediatric or adult population. The co-administration of agents known to inhibit T-cell function has not been formally studied. Administration of low-dose steroids as per the cytokine release syndrome treatment algorithm does not impact the expansion and persistence of CAR-T cells. The co-administration of agents known to stimulate T-cell function has not been investigated and the effects are unknown.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-01T16:53:00Z · SHA-256 5fdcf1c90a6a6d90b0efde33fc48824329dc1e6d597877d217fad0263b61de71 · Passage 2368c62537c8be03eed98b2fe4a621d247319d45470bbd03c2295feecb6f9689 · Zeichen 0–523 im Abschnitt